HDFC Pharma and Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

HDFC Pharma and Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹100 & Lump. ₹100

AUM (Fund size)

₹3,501 Cr

Lock In Period

N/A

Expense Ratio

2.11

Exit Load

In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment.No Exit Load is payable if units are redeemed / switchedout after 30 days from the date of allotment.

Benchmark

BSE Healthcare

HDFC Pharma and Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M-0.06-0.291.18
6M16.051.6719.13
1Y21.753.0323.31
3Y28.9913.51122.39

Portfolio Analysis

  • Equity: 96.77%
  • Debt: 3.23%
  • Others
As on: 2026-09-30
View allocation % by

1. Divis Laboratories Ltd.9.39%
2. Sun Pharmaceutical Industries Ltd.8.28%
3. Alkem Laboratories Ltd.4.64%
4. Cipla Ltd.4.15%
5. Torrent Pharmaceuticals Ltd.3.65%
6. Lupin Ltd.3.55%
7. Neuland Laboratories Limited3.24%
8. Shilpa Medicare Ltd3.23%
9. Dr Reddys Laboratories Ltd.3.19%
10. Acutaas Chemicals Limited3.18%
11. Anthem Biosciences Limited3.17%
12. Ipca Laboratories Ltd.2.98%
13. Rubicon Research Limited2.52%
14. Glenmark Pharmaceuticals Ltd.2.09%
15. Zydus Lifesciences Limited1.82%
16. Gland Pharma Ltd.1.78%
17. Wockhardt Ltd.1.71%
18. Sai Life Sciences Limited1.58%
19. Biocon Ltd.1.47%
20. SYMBIOTEC PHARMALAB LIMITED1.36%
21. CORONA REMEDIES LIMITED1.04%
22. Entero Healthcare Solutions Limited1.01%
23. Jubilant Pharmova Limited0.93%
24. Eris Lifesciences Ltd0.92%
25. Novartis India Ltd.0.55%
26. BAJAJ HEALTHCARE LIMITED0.53%
27. Cohance Lifesciences Limited0.32%

1. Apollo Hospitals Enterprise Ltd.3.69%
2. Max Healthcare Institute Limited3.61%
3. Aster DM Quality Care Limited3.56%
4. Global Health Limited2.72%
5. Krishna Institute Of Medical Sciences Limited2.10%
6. Molbio Diagnostics Limited2.01%
7. Vijaya Diagnostic Centre Limited2.00%
8. Jupiter Life Line Hospitals Limited1.68%
9. Metropolis Healthcare Ltd.1.67%
10. Thyrocare Technologies Ltd.1.10%
No Data Found
No Data Found

About Fund HDFC Pharma and Healthcare Fund Growth

HDFC Pharma and Healthcare Fund Growth managed by HDFC Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹3,501 Crore. The fund benchmarks its performance against the BSE Healthcare while maintaining an expense ratio of 2.11. Under the expert guidance of Nikhil Mathur ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Nikhil Mathur

Mr. Nikhil Mathur holds PGDM - IMT, Ghaziabad, B.E. (Civil) - PEC, Chandigarh, CFA (USA) level 3 cleared. He has over 7 years of experience in equity research and 2 years in financial advisory.

Peer Comparison

HDFC Pharma and Healthcare Fund Growth FAQs

HDFC Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of HDFC Pharma and Healthcare Fund Growth is 2.11. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

HDFC Pharma and Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : -0.06%
  • 6 Months : 16.05%
  • 1 Year : 21.75%
  • 3 Years : 28.99%
Returns of HDFC Pharma and Healthcare Fund Growth are updated daily based on NAV of ₹ 21.169 as on Oct 30,2026. Since inception, the return has been 114.63%.

You can invest in HDFC Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of HDFC Pharma and Healthcare Fund Growth is ₹3,501 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in HDFC Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
  • Daily Research Calls
  • ₹0 AMC for First Year
  • Dedicated RM Support
Open a Free Demat Account
+ Free 1st Year AMC